Join us Dec. 1-3 in New Orleans for the Digiday Programmatic Marketing Summit
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Walmart, Target, Kroger swap name brands for private labels in Thanksgiving meal deals
Walmart’s website says its meal costs 25% less than the basket it offered last year, and that the turkey was at the lowest price since 2019.
Amid search wars, Google touts YouTube, display inventory to advertisers
Google is pushing Demand Gen and YouTube to ad partners, hedging against the inevitable erosion of its search business by AI chatbots.
Future of Marketing Briefing: The agentic turn inside programmatic advertising
The arrival of the Agentic RTB Framework this week lands as this week lands as the third agentic standard in under a month.